NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY

Neurotoxicity is a common occurrence and a major form of morbidity in adult patients with relapsed or refractory (R/R) diffuse large B cell lymphoma (DLBCL) patients treated with anti-CD19 directed chimeric antigen receptor (CAR) T-cell therapy. Variables related to the incidence and severity of neu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Yuen, Carlen, Riedell, Peter, Artz, Andrew, Kosuri, Satyajit, Kelly, Thomas, Wu, Shasha, Reder, Anthony, Rezania, Kourosh, Soliven, Betty, Xie, Tao, Mastrianni, James, Park, Deric, Klejch, Wesley, Ali, Saad, Bishop, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Neurological Complications of Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651666/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.529
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados